A detailed history of True Mark Investments, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, True Mark Investments, LLC holds 134,414 shares of ABCL stock, worth $365,606. This represents 0.11% of its overall portfolio holdings.

Number of Shares
134,414
Previous 109,957 22.24%
Holding current value
$365,606
Previous $325 Million 7.37%
% of portfolio
0.11%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$2.39 - $3.49 $58,452 - $85,354
24,457 Added 22.24%
134,414 $349 Million
Q1 2024

Apr 15, 2024

BUY
$4.29 - $5.97 $56,216 - $78,230
13,104 Added 13.53%
109,957 $498 Million
Q4 2023

Jan 11, 2024

BUY
$3.91 - $5.93 $378,695 - $574,338
96,853 New
96,853 $553 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $776M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track True Mark Investments, LLC Portfolio

Follow True Mark Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Mark Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Mark Investments, LLC with notifications on news.